353 related articles for article (PubMed ID: 7672807)
1. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
Smith GA; Henderson IC
Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
[No Abstract] [Full Text] [Related]
2. High-dose therapy in breast cancer: out of favor but not out of promise.
Glück S; Stewart D
Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes.
Peters WP
Important Adv Oncol; 1995; ():215-30. PubMed ID: 7672808
[No Abstract] [Full Text] [Related]
4. [Autologous hematopoietic stem cell transplantation for the treatment of breast cancer].
Mukaiyama T; Okamoto R; Sasaki T
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1731-40. PubMed ID: 7574803
[TBL] [Abstract][Full Text] [Related]
5. [Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer].
Rühl U
Strahlenther Onkol; 2000 Apr; 176(4):196-7. PubMed ID: 10812394
[No Abstract] [Full Text] [Related]
6. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
Peppercorn J; Herndon J; Kornblith AB; Peters W; Ahles T; Vredenburgh J; Schwartz G; Shpall E; Hurd DD; Holland J; Winer E
Cancer; 2005 Oct; 104(8):1580-9. PubMed ID: 16118805
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.
Winer EP; Lindley C; Hardee M; Sawyer WT; Brunatti C; Borstelmann NA; Peters W
Psychooncology; 1999; 8(2):167-76. PubMed ID: 10335560
[TBL] [Abstract][Full Text] [Related]
8. [High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy in primary breast cancer. An analysis of a systematic Cochrane review].
Nielsen DL; Svane IM
Ugeskr Laeger; 2004 Nov; 166(46):4148-50. PubMed ID: 15565849
[No Abstract] [Full Text] [Related]
9. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
[TBL] [Abstract][Full Text] [Related]
10. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer.
Peters WP; Ross M; Vredenburgh JJ; Hussein A; Rubin P; Dukelow K; Cavanaugh C; Beauvais R; Kasprzak S
Semin Oncol; 1994 Aug; 21(4 Suppl 7):25-31. PubMed ID: 7916487
[TBL] [Abstract][Full Text] [Related]
11. [High dose chemotherapy versus conventional chemotherapy in metastasing breast cancer. An analysis of a systematic Cochrane review].
Nielsen DL; Svane IM
Ugeskr Laeger; 2004 Nov; 166(46):4145-7. PubMed ID: 15565848
[No Abstract] [Full Text] [Related]
12. Peripheral blood stem cell transplant in breast cancer.
Crilley P; Goldstein LJ
Semin Oncol; 1995 Jun; 22(3):238-49. PubMed ID: 7777868
[No Abstract] [Full Text] [Related]
13. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
Shi Y; Pan F; Han X
Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy and autologous bone marrow support for breast cancer.
Peters WP
Important Adv Oncol; 1991; ():135-50. PubMed ID: 1869274
[No Abstract] [Full Text] [Related]
15. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
[TBL] [Abstract][Full Text] [Related]
16. Dose intensity studies in breast cancer--autologous bone marrow transplantation.
Hortobagyi GN; Dunphy F; Buzdar AU; Spitzer G
Prog Clin Biol Res; 1990; 354B():195-209. PubMed ID: 2236166
[No Abstract] [Full Text] [Related]
17. Isolated/primary CNS relapse in women in remission after ABMT for metastatic breast cancer.
Ellis ED; Williams SF
Bone Marrow Transplant; 1992 Feb; 9(2):147-9. PubMed ID: 1315184
[No Abstract] [Full Text] [Related]
18. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow.
Brockstein BE; Williams SF
Stem Cells; 1996 Jan; 14(1):79-89. PubMed ID: 8820954
[TBL] [Abstract][Full Text] [Related]
20. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
